PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1532859
PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1532859
Tissue Glue and Bio-Adhesive Sealants Market size was valued at USD 2,165.45 Million in 2023, expanding at a CAGR of 8.5% from 2024 to 2032.
The tissue glue and bio-adhesive sealants market comprises products designed for surgical wound closure and tissue bonding, enhancing healing and minimizing complications. The increasing number of surgical procedures is a significant driver, with the World Health Organization estimating that around 234 million surgeries are performed globally each year. Furthermore, the rising demand for minimally invasive procedures is boosting the use of adhesive technologies, which provide benefits such as reduced recovery time and lower infection rates. However, the market faces restraints such as regulatory challenges and the high costs associated with advanced adhesive products. Technological advancements, such as the development of bio-compatible and biodegradable adhesives gaining traction in applications like orthopedic and cardiovascular surgeries, as well as trauma care, are creating opportunities and positioning tissue glues and bio-adhesive sealants as essential components in modern surgical practices.
Tissue Glue and Bio-Adhesive Sealants Market- Market Dynamics
Rising Demand for Minimally Invasive Procedures Fuels Growth in Tissue Glue and Bio-Adhesive Sealants Market
The rising demand for minimally invasive procedures is significantly fueling growth in the tissue glue and bio-adhesive sealants market, as these adhesives offer advantages like reduced trauma and quicker recovery times. According to the American College of Surgeons, minimally invasive surgeries account for over 80% of procedures performed in certain specialties, highlighting their increasing prevalence. Additionally, the World Health Organization reports that such techniques result in lower infection rates and shorter hospital stays, further driving their adoption. As surgical techniques evolve, the need for effective tissue adhesives that promote faster healing and better patient outcomes has become paramount. This trend is prompting healthcare providers to incorporate tissue glues and bio-adhesive sealants into their practices, making them essential tools in modern surgical interventions.
Tissue Glue and Bio-Adhesive Sealants Market- Key Insights
As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 8.5% over the forecast period (2024-2032)
Based on product type segmentation, Fibrin sealants were predicted to show maximum market share in the year 2023
Based on Component segmentation, Natural was the leading type in 2023
Based on Application segmentation, Surgical was the leading type in 2023
Based on region, North America was the leading revenue generator in 2023
The Global Tissue Glue and Bio-Adhesive Sealants Market is segmented based on Product Type, Component, Application, End-User, and Region.
The market is divided into four categories based on product type: Fibrin Sealants, Collagen-Based Adhesives, Gelatin-Based Adhesives, and Synthetic Adhesives. Fibrin sealants lead the tissue glue and bio-adhesive sealants market, valued for their effectiveness in promoting hemostasis and tissue adhesion during surgeries. They are followed by collagen-based adhesives, recognized for their biocompatibility and ability to facilitate tissue regeneration. Gelatin-based adhesives and synthetic adhesives also play significant roles, offering versatile solutions in surgical settings.
The market is divided into two categories based on components: natural and synthetic types, with natural adhesives leading due to their biocompatibility and reduced risk of adverse reactions, while synthetic adhesives offer versatility and durability in various surgical applications.
Tissue Glue and Bio-Adhesive Sealants Market- Geographical Insights
North America dominates the market, driven by a high number of surgical procedures and advanced healthcare facilities. The presence of key players and significant investments in research and development further enhance the region's leadership. Europe follows closely, with countries like Germany and the UK adopting innovative surgical techniques and minimally invasive procedures, leading to increased demand for adhesive technologies. In the Asia-Pacific region, rapid economic growth, improving healthcare infrastructure, and a rising number of surgical interventions in countries like India and China are driving market expansion. Additionally, Latin America and the Middle East are emerging markets, with governments focusing on enhancing healthcare services and adopting advanced medical technologies, creating opportunities for growth in tissue glue and bio-adhesive sealants across these regions.
Key companies such as Johnson & Johnson, B. Braun, and Medtronic dominate with their extensive portfolios of advanced adhesive products designed for various surgical applications. These firms invest heavily in research and development to enhance product performance and develop new technologies that improve patient outcomes. Emerging companies are also making strides by offering specialized adhesive solutions tailored to specific surgical needs, fostering innovation and competition. Collaborations and partnerships between healthcare providers and manufacturers are common, aiming to integrate cutting-edge adhesive technologies into surgical practices. For instance, In June 2023, H.B. Fuller completed strategic acquisitions of Adhesion Biomedical and XCHEM International, expanding its medical adhesives portfolio and manufacturing capabilities in the Middle East and North Africa to drive profitable growth and innovation in highly specified applications. Additionally, a growing emphasis on sustainability is prompting companies to explore eco-friendly adhesive options, further enhancing their competitive positioning in a market that increasingly values both efficacy and environmental responsibility.
In March 2023, H.B. Fuller launched Swift(R)melt 1515-I, a new bio-compatible adhesive for medical tape applications that delivers effective high tack, secure, and quick bonding, and is certified as non-toxic for use in hospitals and home care settings.
In April 2022, Henkel partnered with its Tissue 2022, a leading trade fair for the tissue and hygiene industry, to showcase its innovative adhesive solutions that enable manufacturers to produce sustainable, high-quality tissue and hygiene products.
GLOBAL TISSUE GLUE AND BIO-ADHESIVE SEALANTS MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS
Advanced Medical Solutions Group plc
B. Braun Melsungen AG
Baxter International Inc.
C.R. Bard, Inc.
Cardinal Health, Inc.
Cohera Medical, Inc.
CryoLife Inc.
CSL Behring
Ethicon Inc. (Johnson & Johnson)
Integra LifeSciences Corporation
Mallinckrodt Pharmaceuticals
Medtronic Plc
Sanofi S.A.
Takeda Pharmaceutical Company Limited
Tissuemed Ltd.
Vivostat A/S
Others